U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
December 14, 2000
SELECT THERAPEUTICS, INC.
------------------------------------------------------------
(Exact name of small business issuer as
specified in its charter)
Delaware 000-27353 98-0169105
State or other jurisdiction Commission (I.R.S. Employer
incorporation or organization File Number Identification No.)
50 Cummings Park, Woburn, MA 01801
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code:
(781) 939-0995
(Former name, former address and former fiscal year,
if changed since last report)
<PAGE>
Item 7. Financial Statements and Exhibits
(c) Exhibits
16.1 Letter, dated December 15, 2000, from KPMG LLP, Registrant's
former accountant, to the Securities and Exchange Commission.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Select Therapeutics, Inc.
Dated: December 27, 2000 By: /s/ Robert Bender
---------------------
Robert Bender
Chairman of the Board
